Goldie RG et al. |
PAF receptors in guinea-pig and human lung. |
1990 |
Agents Actions Suppl. |
pmid:1964365
|
Alabaster VA et al. |
UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo. |
1991 |
Agents Actions Suppl. |
pmid:1793066
|
Heuer HO |
The effects of hetrazepine PAF antagonists in preclinical models of asthma. |
1991 |
Agents Actions Suppl. |
pmid:1793067
|
Mazzoni L et al. |
Changes in airway sensitivity to histamine are not necessarily paralleled by changed sensitivity to acetylcholine. |
1991 |
Agents Actions Suppl. |
pmid:1793069
|
Billah MM et al. |
Sch 37370: a new drug combining antagonism of platelet-activating factor (PAF) with antagonism of histamine. |
1991 |
Agents Actions Suppl. |
pmid:1793070
|
Saeed SA et al. |
Inhibitory effect of oral ketotifen on ex vivo platelet activating factor-induced platelet aggregation. |
1991 |
Agents Actions Suppl. |
pmid:1793071
|
Hoshiko K et al. |
Histamine(H1) antagonists and airway hyperreactivity in the guinea-pig. |
1991 |
Agents Actions Suppl. |
pmid:1686527
|
Mest HJ et al. |
Effect of BN 52256 and other mediator antagonists on ouabain-induced ventricular fibrillation in sensitized guinea-pigs and on ischemia-induced fibrillation in rats. |
1992 |
Agents Actions Suppl. |
pmid:1632298
|
Koltai M and Braquet PG |
Involvement of PAF in atherogenesis. Brief review. |
1992 |
Agents Actions Suppl. |
pmid:1632308
|
McMillan RM and Carter GW |
Design and development of drugs. |
1991 |
Agents Actions Suppl. |
pmid:1664186
|
Rihoux JP |
The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade. |
1991 |
Agents Actions Suppl. |
pmid:1675836
|
Kurosawa M |
Effect of platelet activating factor on histamine release from rat mast cells. |
1987 |
Agents Actions Suppl. |
pmid:2445185
|
Page CP and Spina D |
The therapeutic relevance of PAF antagonists. |
1989 |
Agents Actions Suppl. |
pmid:2683635
|
Rink TJ |
Stimulus-response coupling mechanisms in human platelets. |
1986 |
Agents Actions Suppl. |
pmid:3028101
|
Baroggi N et al. |
Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. |
1986 |
Agents Actions Suppl. |
pmid:3028108
|
Page CP et al. |
Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs. |
1988 |
Agents Actions Suppl. |
pmid:3051932
|
Muirhead EE |
Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver. |
1987 |
Agents Actions Suppl. |
pmid:3324720
|
Schmitz-Schumann M et al. |
Evidence of PAF release and platelet activation in analgesics-asthma-syndrome. |
1987 |
Agents Actions Suppl. |
pmid:3478999
|
Guinot P et al. |
Effects of BN 52063 on PAF-acether induced weal and flare in man. |
1987 |
Agents Actions Suppl. |
pmid:3479000
|
Lang M et al. |
Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets. |
1987 |
Agents Actions Suppl. |
pmid:3479001
|
Codde JP et al. |
Effects of altered prostanoid and lyso-PAF synthesis by marine oil diets on blood pressure of salt loaded spontaneously hypertensive rats. |
1987 |
Agents Actions Suppl. |
pmid:3481207
|
Morley J |
PAF and airway hyperreactivity; prospects for novel prophylactic anti-asthma drugs. |
1987 |
Agents Actions Suppl. |
pmid:3314417
|
Braquet P et al. |
The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021. |
1987 |
Agents Actions Suppl. |
pmid:3314418
|
Morley J et al. |
Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor. |
1988 |
Agents Actions Suppl. |
pmid:3262989
|
Subissi A and Criscuoli M |
Effects of LG 30435 on different platelet activating factor-induced responses. |
1988 |
Agents Actions Suppl. |
pmid:3262990
|
Heuer H and Casals-Stenzel J |
Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge. |
1988 |
Agents Actions Suppl. |
pmid:3262991
|
Parnham MJ et al. |
Regulation of the oxidative burst of macrophages by lipid mediators. |
1984 |
Agents Actions Suppl. |
pmid:6433680
|
Vargaftig BB |
Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction. |
1983 |
Agents Actions Suppl. |
pmid:6575594
|
Page CP et al. |
PAF-acether: a putative mediator of asthma and inflammation. |
1983 |
Agents Actions Suppl. |
pmid:6575595
|
Madi S et al. |
Allergen-induced bronchospasm in passively sensitized guinea pigs: influence of new substances in comparison to reference compounds. |
1991 |
Agents Actions |
pmid:2058463
|
Braquet P and Esanu A |
New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists. |
1991 |
Agents Actions |
pmid:2058466
|
Northover AM |
Modification by some antagonists of the shape changes of venous endothelial cells in response to inflammatory agents in vitro. |
1990 |
Agents Actions |
pmid:2111079
|
Will PC et al. |
Platelet activating factor as a proinflammatory mediator in acetic-induced colitis in the rat. |
1991 |
Agents Actions |
pmid:1793026
|
Vincent D et al. |
Dissociation between LPS-induced bronchial hyperreactivity and airway edema in the guinea-pig. |
1991 |
Agents Actions |
pmid:1793031
|
McLeod J et al. |
Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on substance P-induced histamine release from rat peritoneal mast cells. |
1990 |
Agents Actions |
pmid:1695435
|
Adolfs MJ et al. |
PAF-acether modifies human peritoneal macrophage cAMP levels in a biphasic fashion. |
1989 |
Agents Actions |
pmid:2540635
|
Neumann M and Kownatzki E |
The effect of adherence on the generation of reactive oxygen species by human neutrophilic granulocytes. |
1989 |
Agents Actions |
pmid:2540640
|
Trebien HA and Calixto JB |
Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. |
1989 |
Agents Actions |
pmid:2660497
|
Bekemeier H and Sänze JU |
Vasodepression ex vivo after administration of inflammatory mediators in vivo in the rat. |
1989 |
Agents Actions |
pmid:2476918
|
Jouquey S et al. |
Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. |
1988 |
Agents Actions |
pmid:2459935
|
Sanchez Crespo M and Nieto ML |
Modulation of PAF biosynthesis in human polymorphonuclear leukocytes. The role of phorbol esters and protein kinases. |
1989 |
Agents Actions |
pmid:2711927
|
Zijlstra FJ et al. |
The effects of PAF-acether and FMLP on eicosanoid production in guinea pig alveolar macrophages. |
1989 |
Agents Actions |
pmid:2711928
|
Nijkamp FP et al. |
Role of platelet activating factor in the endotoxin induced tracheal hyperreactivity to histamine in the guinea pig. |
1989 |
Agents Actions |
pmid:2711929
|
Oliver JL et al. |
Effect of PAF acether on oriented egg phosphatidylcholine multibilayers; interaction with cholesterol; comparison to lyso-PC and lyso-PAF. |
1989 |
Agents Actions |
pmid:2711930
|
Doyle SA et al. |
Further studies on the antinociceptive effects of delta 6-THC-7-oic acid. |
1990 |
Agents Actions |
pmid:2178317
|
Nieminen MM et al. |
Body temperature modulates the effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit. |
1991 |
Agents Actions |
pmid:1862740
|
Jenei B et al. |
Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function). |
1991 |
Agents Actions |
pmid:1862750
|
Kantar A et al. |
Effect of PAF on erythrocyte membrane heterogeneity: a fluorescence study. |
1991 |
Agents Actions |
pmid:1862752
|
Adnot S et al. |
Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. |
1987 |
Agents Actions |
pmid:3115070
|
Carlson RP et al. |
Pharmacologic modulation of PAF-induced mortality in mice. |
1987 |
Agents Actions |
pmid:3120513
|
Anderson GP et al. |
Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites. |
1988 |
Agents Actions |
pmid:3136622
|
Morley J |
Platelet activating factor and asthma. |
1986 |
Agents Actions |
pmid:3099555
|
Cunha FQ et al. |
Failure of PAF-acether to induce in vivo neutrophil migration. |
1988 |
Agents Actions |
pmid:3055873
|
Ramesha CS et al. |
Identification and quantitation of PAF from psoriatic scales. |
1987 |
Agents Actions |
pmid:3687590
|
Friedlander G et al. |
Renal effects of platelet-activating factor in the rat. |
1987 |
Agents Actions |
pmid:3687594
|
Lauri D et al. |
Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin. |
1986 |
Agents Actions |
pmid:3706054
|
Taira M et al. |
Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats. |
1988 |
Agents Actions |
pmid:3407549
|
Mastacchi R et al. |
Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets. |
1986 |
Agents Actions |
pmid:3518359
|
Kusner EJ et al. |
Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat. |
1987 |
Agents Actions |
pmid:3577957
|
Archer CB et al. |
Actions of disodium cromoglycate (DSCG) on human skin responses to histamine, codeine and Paf-acether. |
1985 |
Agents Actions |
pmid:3923788
|
Pirotzky E et al. |
Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney. |
1985 |
Agents Actions |
pmid:4003192
|
Page CP et al. |
Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation. |
1985 |
Agents Actions |
pmid:4003195
|
Page CP et al. |
Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs. |
1985 |
Agents Actions |
pmid:4003196
|
Spicer BA et al. |
An investigation of the involvement of platelet activating factor in the non-histamine immediate hypersensitivity reaction in the rat peritoneal cavity. |
1985 |
Agents Actions |
pmid:4003197
|
Boughton-Smith NK et al. |
Actions of nitric oxide on the acute gastrointestinal damage induced by PAF in the rat. |
1992 |
Agents Actions |
pmid:1279960
|
Perales J et al. |
Neutralization of the oedematogenic activity of Bothrops jararaca venom on the mouse paw by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum. |
1992 |
Agents Actions |
pmid:1295374
|
Wong CW et al. |
Comparative effects of tetrandrine and berbamine on subcutaneous air pouch inflammation induced by interleukin-1, tumour necrosis factor and platelet-activating factor. |
1992 |
Agents Actions |
pmid:1414679
|
Tran A et al. |
Separate induction of human blood platelet aggregation or cytotoxicity by different concentrations of PAF-acether and thrombin. |
1992 |
Agents Actions |
pmid:1414687
|
Northover AM |
In vitro effects of PAF on venous endothelial cell actin disposition. |
1992 |
Agents Actions |
pmid:1509977
|
Okamoto H et al. |
Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor. |
1992 |
Agents Actions |
pmid:1388318
|
Miyagawa H et al. |
The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils. |
1992 |
Agents Actions |
pmid:1456179
|
Lewis AJ et al. |
The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation. |
1984 |
Agents Actions |
pmid:6152379
|
Benveniste J |
Platelet-activating factor (PAF-acether): present status. |
1981 |
Agents Actions |
pmid:6176101
|
Northover AM and Northover BJ |
Lectin-induced increase in microvascular permeability to colloidal carbon in vitro may involve protein kinase C activation. |
1994 |
Agents Actions |
pmid:7942320
|
Tubaro E et al. |
In vitro and in vivo impact of a new glycosphingolipid on neutrophils. |
1994 |
Agents Actions |
pmid:7879694
|
Canale P et al. |
TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock. |
1994 |
Agents Actions |
pmid:7879698
|
Raff GW et al. |
Procoagulant property of platelet activating factor (PAF). |
1993 |
Agents Actions |
pmid:8273543
|
Meats JE et al. |
Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages. |
1993 |
Agents Actions |
pmid:8273553
|
Thomas TK et al. |
Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat. |
1993 |
Agents Actions |
pmid:8273566
|
Glaser KB et al. |
Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). |
1993 |
Agents Actions |
pmid:8273577
|
Kantar A et al. |
Effect of PAF on human lymphocyte membranes: a fluorescence study. |
1993 |
Agents Actions |
pmid:8317302
|
Boonen GJ et al. |
Activation of neutrophil migration by dioctanoyl-sn-glycerol and fMet-Leu-Phe is controlled by different pathways. |
1993 |
Agents Actions |
pmid:8317308
|
Murphy G |
Report of the 14th meeting of the British Inflammation Research Association. Topic: cellular and molecular aspects of inflammatory bowel disease. |
1993 |
Agents Actions |
pmid:8480529
|
Perret BA et al. |
Binding of bovine factor VIII-coated colloidal gold particles to receptors on platelet membranes. |
1981 |
Agents Actions |
pmid:6803540
|
Denburg JA et al. |
Platelet activating factor: regulation by mast cells and aspirin. |
1984 |
Agents Actions |
pmid:6711391
|
Lecrubier C et al. |
Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. |
1983 |
Agents Actions |
pmid:6858789
|
Jouvin-Marche E et al. |
Platelet-activating factor (PAF-acether), an activator of neutrophil functions. |
1982 |
Agents Actions |
pmid:6299078
|
Caillard CG et al. |
Hypotensive activity of PAF-acether in rats. |
1982 |
Agents Actions |
pmid:6299079
|
Mencia-Huerta JM et al. |
Is platelet-activating factor (PAF-acether) synthesis by murine peritoneal cells (PC) a two-step process? |
1981 |
Agents Actions |
pmid:7053072
|
Vargaftig BB |
Platelet-activating factor (PAF-acether) |
1982 |
Agents Actions |
pmid:7164939
|
Bette P and Bienvenue A |
Exchange of a spin-labeled analog of PAF-acether between micelles, serum albumin and model membranes. |
1982 |
Agents Actions |
pmid:7164940
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of PAF-acether. Preliminary results after the intravenous administration of a 3H-labelled product to the rabbit. |
1982 |
Agents Actions |
pmid:7164941
|
Morgat JL et al. |
Radio-labelling of 1-O-alkyl, 2-O-acetyl, sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acether. |
1982 |
Agents Actions |
pmid:7164942
|
Convert O et al. |
1H NMR of PAF-acether: influence of solvent on its structure. |
1982 |
Agents Actions |
pmid:7164943
|
Borrel MC et al. |
Additional techniques for the total synthesis of PAF-acether. |
1982 |
Agents Actions |
pmid:7164944
|
Vargaftig BB et al. |
Platelet-tissue interaction: role of platelet-activating factor (PAF-acether). |
1980 |
Agents Actions |
pmid:7270336
|
Heller R et al. |
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells. |
1993 |
Agents Actions |
pmid:7517616
|
Czarnetzki BM and Benveniste J |
Effect of synthetic PAF-acether on human neutrophil function. |
1981 |
Agents Actions |
pmid:7041568
|
Camussi G et al. |
Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2). |
1981 |
Agents Actions |
pmid:7041569
|
de Bernardis E et al. |
Protective effects of papaverine salicylate in mouse ear dermatitis and PAF-induced rat paw oedema. |
1994 |
Agents Actions |
pmid:7847181
|